August 3, 2026 · 6 min read
The federal indirect-cost rule has an NIH exception. The award still controls.
The 2024 Uniform Guidance raised the government-wide de minimis ceiling, but NIH returned to its prior indirect-cost provisions in April 2026. A portfolio assumption is no longer enough; the agency, award, and applicable cost base have to be identified.
Read the evidence brief